TMCnet News

The Top 100 Developers of Cancer In-Vitro Diagnostics Tests 2017 - Research and Markets

[June 30, 2017]

The Top 100 Developers of Cancer In-Vitro Diagnostics Tests 2017 - Research and Markets

Research and Markets has announced the addition of the "The Top 100 Developers of Cancer In-Vitro Diagnostics Tests" report to their offering.

This unique and comprehensive report identifies and profiles the leading 100 developers of cancer in-vitro diagnostics tests.

Report Target (News - Alert) Market:

1) In-Vitro Diagnostics Companies

Usage: competitive/financial analysis and strategic partner/alliance identification.

2) Suppliers

The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests is perfect for suppliers of raw materials, technology and services to identify top potential customers.

3) Distributors

This report is ideal for distributors of in-vitro diagnostic instruments and tests to identify the leading manufacturers with the best products.

4) Industry Associations:

The Top 100 Developers Of Cancer In-Vitro Diagnostics Tests is a useful reference tool for in-vitro diagnostic associations.

Note: Most people will be aware of some of the major developers of cancer in-vitro diagnostics tests such as Accugenomics, Inc., Agendia Inc., Biocept, Inc., GeneNews Limited and OvaGene Oncology, Inc. but this major new report looks at all 100 of the top companies.

Report data field structure is as follows:

- Company Name

- Address

- Telephone

- Fax

- Email

- Website

- Year Established

- Number of Employees

- Key Executives

- Company Description

- Products